| Dr John Timothy Carmack, MD, MPH | |
|
618 Hospital Rd, Tappahannock, VA 22560-5000 | |
| (804) 443-6297 | |
| Not Available |
| Full Name | Dr John Timothy Carmack |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 35 Years |
| Location | 618 Hospital Rd, Tappahannock, Virginia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023034972 | NPI | - | NPPES |
| 005639301 | Medicaid | VA | |
| 005829623 | Medicaid | VA | |
| 1023034972 | Medicaid | VA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Beginnings Therapy Services Llc | 4880982974 | 3 |
News Archive
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
Arena Pharmaceuticals, Inc. announced today that it has agreed to sell 9,953,250 shares of its common stock, at a price of $1.65775 per share, and approximately 9,953 shares of its Series D Convertible Preferred Stock, at a price of $1,657.75 per share, in a registered direct public offering to entities affiliated with Deerfield Management, a healthcare investment organization.
U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
An online guide about interventions in early childhood that can help prevent drug use and other unhealthy behaviors was launched today by the National Institute on Drug Abuse, part of the National Institutes of Health.
› Verified 6 days ago
| Entity Name | New Beginnings Therapy Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811355597 PECOS PAC ID: 4880982974 Enrollment ID: O20161005000477 |
News Archive
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
Arena Pharmaceuticals, Inc. announced today that it has agreed to sell 9,953,250 shares of its common stock, at a price of $1.65775 per share, and approximately 9,953 shares of its Series D Convertible Preferred Stock, at a price of $1,657.75 per share, in a registered direct public offering to entities affiliated with Deerfield Management, a healthcare investment organization.
U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
An online guide about interventions in early childhood that can help prevent drug use and other unhealthy behaviors was launched today by the National Institute on Drug Abuse, part of the National Institutes of Health.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Timothy Carmack, MD, MPH 3450 Maidens Rd, Powhatan, VA 23139-4015 Ph: (804) 928-8167 | Dr John Timothy Carmack, MD, MPH 618 Hospital Rd, Tappahannock, VA 22560-5000 Ph: (804) 443-6297 |
News Archive
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
Arena Pharmaceuticals, Inc. announced today that it has agreed to sell 9,953,250 shares of its common stock, at a price of $1.65775 per share, and approximately 9,953 shares of its Series D Convertible Preferred Stock, at a price of $1,657.75 per share, in a registered direct public offering to entities affiliated with Deerfield Management, a healthcare investment organization.
U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
An online guide about interventions in early childhood that can help prevent drug use and other unhealthy behaviors was launched today by the National Institute on Drug Abuse, part of the National Institutes of Health.
› Verified 6 days ago
Anastasia Dumbra Cleary, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Mt Clement Park, Ste C, Tappahannock, VA 22560 Phone: 804-443-6063 Fax: 804-443-6005 | |
Allen Y Tsui, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1362 Tappahannock Blvd, Tappahannock, VA 22560 Phone: 804-443-5378 Fax: 804-443-9667 | |
Thomas K Irungu, MD, MPH Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Mt Clement Park, Suite A, Tappahannock, VA 22560 Phone: 804-443-8610 Fax: 804-443-8620 | |
Lisa Petty, FNP-C Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-8628 | |
Ryan Gentry Williams, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Mt Clement Park, Suite C, Tappahannock, VA 22560 Phone: 804-443-6063 Fax: 804-443-6005 | |
Charles M. Helton, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-6282 Fax: 804-443-6051 | |
Robert E Briggs, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 658 Hospital Rd, Suite 303, Tappahannock, VA 22560 Phone: 804-443-6062 Fax: 804-443-6259 |